Arcadia Biosciences Inc

NASDAQ RKDA

Download Data

Arcadia Biosciences Inc Shareholders' Equity for the year ending December 31, 2023: USD 12.84 M

Arcadia Biosciences Inc Shareholders' Equity is USD 12.84 M for the year ending December 31, 2023, a -38.95% change year over year. Shareholders' Equity is the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Arcadia Biosciences Inc Shareholders' Equity for the year ending December 31, 2022 was USD 21.03 M, a -32.35% change year over year.
  • Arcadia Biosciences Inc Shareholders' Equity for the year ending December 31, 2021 was USD 31.09 M, a 12.15% change year over year.
  • Arcadia Biosciences Inc Shareholders' Equity for the year ending December 31, 2020 was USD 27.73 M, a 259.83% change year over year.
  • Arcadia Biosciences Inc Shareholders' Equity for the year ending December 31, 2019 was USD 7.71 M, a -39.88% change year over year.
NASDAQ: RKDA

Arcadia Biosciences Inc

CEO Ms. Pamela Haley
IPO Date May 15, 2015
Location United States
Headquarters 202 Cousteau Place, Davis, CA, United States, 95618
Employees 21
Sector Consumer Defensive
Industry Packaged foods
Description

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Similar companies

SENEA

Seneca Foods Corp A

NA

NA

BRID

Bridgford Foods Corporation

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email